Testosterone gel: Clinical Trials

11 trials of Testosterone gel, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 2 recruiting, 1 terminated, 1 unknown. 11 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 311Completed 7, Recruiting 2, Terminated 1, Unknown 1
Phase 21Completed 1

Follow Testosterone gel: new trials by email Literature Review of Testosterone gel trials Research Report on Testosterone gel

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sex Steroids Balance for Metabolic and Reproductive Health in Klinefelter Syndrome
Anastrozole, Semaglutide, human chorionic gonadotropin - Klinefelter Syndrome
Phase 3RecruitingGeorgios Papadakis1502023-03-212026-05-11
Impact of Peri-operative tEstosterone Levels on oNcological and Functional Outcomes in RadiCal prostatEctomy
Testosterone gel, Placebo - Prostatic Neoplasms, Hypogonadism
Phase 3RecruitingCanisius-Wilhelmina Hospital1402022-12-122025-05-02
Testosterone Treatment in a Patient With 17β-hydroxysteroid Dehydrogenase Type 3 Deficiency: an N-of-1 Study
Testosterone gel, Placebo - Disorder of Sex Development, 46,XY
Phase 3UnknownErasmus Medical Center12021-06-012021-04-05
Testosterone TRANSdermal Gel for Poor Ovarian Responders Trial
Testosterone gel, Placebo gel - Infertility, Poor Ovarian Response
Phase 3TerminatedFundacion Dexeus2902015-04-012024-05-22
The Testosterone Trials in Older Men
AndroGel® (testosterone gel), Placebo - Andropause
Phase 3CompletedUniversity of Pennsylvania7902009-11-012019-02-21
Hormone and Information Processing Study
testosterone gel, placebo gel - Mild Cognitive Impairment, Alzheimer's Disease
Phase 3CompletedUniversity of Washington222009-07-012014-07-14
PROS-1-Male Hormonal Contraceptive Regimens on Prostate Tissue
Testosterone gel, Dutasteride, Depo-Medroxyprogesterone (DMPA) - Healthy
Phase 2 / Phase 3CompletedUniversity of Washington322009-01-012013-11-15
Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
testosterone gel, placebo gel - Hypoactive Sexual Desire Disorder
Phase 3CompletedBioSante Pharmaceuticals5752008-03-012013-01-10
Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women
testosterone gel, placebo gel - Hypoactive Sexual Desire Disorder
Phase 3CompletedBioSante Pharmaceuticals36562008-01-012021-10-29
Safety and Efficacy of LibiGel® for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
testosterone gel, placebo gel - Hypoactive Sexual Desire Disorder
Phase 3CompletedBioSante Pharmaceuticals5972006-12-012013-01-10
Co-Administering Testosterone With PDE5 Inhibitors in ED Patients Non Responders to PDE5 Inhibitors Alone
Testosterone gel, testosterone, placebo gel - Erectile Dysfunction, Hypogonadism
Phase 3CompletedSELARL du Dr Jacques BUVAT1732005-10-012008-08-25

Conditions studied

Sexual Dysfunctions, Psychological (3)  ·  Hypogonadism (2)  ·  Infertility (2)  ·  Alzheimer Disease (1)  ·  Anemia (1)  ·  Breast Neoplasms (1)  ·  Cognitive Dysfunction (1)  ·  Disorder of Sex Development, 46,XY (1)  ·  Erectile Dysfunction (1)  ·  Klinefelter Syndrome (1)  ·  Metabolic Syndrome (1)  ·  Prostatic Neoplasms (1)

Sponsors

BioSante Pharmaceuticals (3)  ·  University of Washington (2)  ·  Canisius-Wilhelmina Hospital (1)  ·  Erasmus Medical Center (1)  ·  Fundacion Dexeus (1)  ·  Georgios Papadakis (1)  ·  SELARL du Dr Jacques BUVAT (1)  ·  University of Pennsylvania (1)

Countries

United States (6)  ·  Canada (3)  ·  Netherlands (2)  ·  Switzerland (2)  ·  Belgium (1)  ·  Denmark (1)  ·  France (1)  ·  Spain (1)

Top investigators

Michael C Snabes, MD, PhD (3)  ·  Diederik Somford, MD, PhD (1)

Results publications

PMID 38224135, PMID 21761342, PMID 22172433, PMID 25548978, PMID 26554661, PMID 26886521, PMID 27355400, PMID 28241231, PMID 28241237, PMID 28241355, PMID 28241356, PMID 29253154, PMID 30366567, PMID 31784747, PMID 32785689, PMID 35041751, PMID 40514343, PMID 41461161, PMID 41680203

NIH funding

2014 (1), R01AG027156 (1), R01AG037679 (1)